Parkinson's Impact Scale (PIMS) - best symptom financial security scale

General Details:

Name:
Parkinson's Impact Scale (PIMS) - best symptom financial security scale
Steward:
NINDS
Definition:
Financial Security: Refers to your ability to support yourself and your family and pay your medical costs. If your symptoms fluctuate complete for best. As part of PIMS Questionnaire
Registration Status:
Qualified

Permissible Values:

Data Type:
Value List
Unit of Measure:
Ids:
Value Code Name Code Code System Code Description
0 no change no change
1 slight slight
2 Moderate Moderate
3 moderately severe moderately severe
4 severe severe

Designations:

Designation:
Parkinson's Impact Scale (PIMS) - best symptom financial security scale
Tags:

Designations:

Definition:
Financial Security: Refers to your ability to support yourself and your family and pay your medical costs. If your symptoms fluctuate complete for best. As part of PIMS Questionnaire
Tags:

Reference Documents:

ID:
Title:
URI:
Provider Org:
Language Code:
Document:
Calne, S., Schulzer, M., Mak, E., Guyette, C., Rohs, G., Hatchard, S., . . . Pegler, S. (1996). Validating a quality of life rating scale for idiopathic parkinsonism: Parkinson's Impact Scale (PIMS). Parkinsonism Relat Disord, 2(2), 55&#8211;61. Erratum: Parkinsonism & Related Disorders Vol. 2 No. 4, p. 237, 1996.<br /><br />Calne, S. M., Mak, E., Hall, J., Fortin, M. J., King, P., McInnes, G., . . . Schulzer, M. (2003). Validating a quality-of-life scale in caregivers of patients with Parkinson's disease: Parkinson's Impact Scale (PIMS). Adv Neurol, 91, 115&#8211;122. <br /><br />Schulzer, M., Mak, E., & Calne, S. M. (2003). The psychometric properties of the Parkinson's Impact Scale (PIMS) as a measure of quality of life in Parkinson's disease. Parkinsonism Relat Disord, 9(5), 291&#8211;294. <br /><br />Serrano-Duenas, M., & Serrano, S. (2008). Psychometric characteristics of PIMS--compared to PDQ-39 and PDQL--to evaluate quality of life in Parkinson's disease patients: validation in Spanish (Ecuadorian style). Parkinsonism Relat Disord, 14(2), 126&#8211;132. <br /><br />Suchowersky, O., Bailey, P., Pourcher, E., Bulger, L., & Facciponte, G. (2001). Comparison of two dosages of tolcapone added to levodopa in nonfluctuating patients with PD. Clin Neuropharmacol, 24(4), 214&#8211;220.

Identifiers:

Source:
NLM
Id:
dhRwVJzojF3
Version:
3.1
Source:
NINDS
Id:
C10217
Version:
3
Source:
BRICS Variable Name
Id:
PIMSBstSymptmFinSecScale
Version: